Abstract
Neisseria meningitidis serogroup B is a significant cause of septicaemia and meningitis worldwide. This phase 3 randomised, controlled study assessed the immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine, 4CMenB, in healthy Korean adolescents. 264 adolescents (11-17 years old) were randomised to receive two doses, one month apart, of 4CMenB or control vaccines [placebo followed by one dose of a quadrivalent meningococcal ACWY glycoconjugate vaccine (MenACWY-CRM)]. Immunogenicity was evaluated by serum bactericidal assay with human complement (hSBA) against three serogroup B test strains specific for individual vaccine antigens (fHbp, NadA or PorA P1.4), and by enzyme-linked immunosorbent assay (ELISA) against the NHBA antigen. Solicited reactions and adverse events (AEs) were assessed. One month post-second vaccination, 98%, 97%, and 97% of subjects in the 4CMenB group achieved hSBA titres ≥ 4 against the fHbp, NadA and PorA test strains, respectively, while percentages in the Control group were comparable to baseline (27%, 16%, and 17%, respectively). Geometric mean ELISA concentrations (GMCs) against NHBA increased 52-fold relative to baseline in the 4CMenB group, while there was no substantial i...Continue Reading
References
Nov 1, 1972·The Journal of Infectious Diseases·F A WyleJ P Lowenthal
Jun 1, 1969·The Journal of Experimental Medicine·I GoldschneiderM S Artenstein
Mar 10, 2000·Science·M PizzaR Rappuoli
Jul 11, 2006·Proceedings of the National Academy of Sciences of the United States of America·Marzia M GiulianiMariagrazia Pizza
May 30, 2009·Vaccine·Lee H HarrisonMary E Ramsay
Nov 16, 2010·The Lancet Infectious Diseases·Hannah ChristensenCaroline L Trotter
Jan 21, 2012·Lancet·María Elena SantolayaUNKNOWN V72P10 Meningococcal B Adolescent Vaccine Study group
Feb 10, 2012·JAMA : the Journal of the American Medical Association·Nicoletta GossgerUNKNOWN European MenB Vaccine Study Group
Feb 11, 2012·Korean journal of pediatrics·Jong-Hyun Kim
Jun 6, 2012·Yonsei Medical Journal·Areum DureyJin-Soo Lee
Jan 18, 2013·Lancet·Timo VesikariUNKNOWN EU Meningococcal B Infant Vaccine Study group
Mar 22, 2013·MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports·Amanda C CohnUNKNOWN Centers for Disease Control and Prevention (CDC)
Jun 29, 2013·Korean journal of pediatrics·Dae Sun JoUNKNOWN Korean Pediatric Society, Committee on Infectious Diseases
Jul 3, 2013·Human Vaccines & Immunotherapeutics·Maria Elena SantolayaPeter M Dull
May 13, 2014·Immunotherapy·Susanna EspositoJeffrey Stoddard
Jan 22, 2015·Expert Review of Vaccines·Jane WhelanMirna Robert-Du Ry van Beest Holle
Mar 22, 2015·Vaccine·Stan L BlockIgor Smolenov
Apr 29, 2015·Pediatrics·Lucy A McNamaraThomas A Clark
Jul 19, 2015·Vaccine·Terry NolanPeter Dull
Aug 2, 2015·Vaccine·Kirsten P PerrettTerry Nolan
Citations
Aug 11, 2016·PloS One·Maria DominaConcetta Beninati
Jan 18, 2018·Human Vaccines & Immunotherapeutics·Nan-Chang ChiuDaniela Toneatto
Jun 22, 2018·Human Vaccines & Immunotherapeutics·A R GiulianiL Fabiani
Nov 17, 2016·Clinical and Vaccine Immunology : CVI·Serena GiuntiniDan M Granoff
May 3, 2018·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Dirk MentzerBrigitte Keller-Stanislawski
Sep 18, 2020·MSphere·Margherita BodiniAlessandro Muzzi
Jan 9, 2021·MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports·Sarah A MbaeyiJessica R MacNeil
May 30, 2021·Vaccine·Courtney GidengilSusanne Hempel
Aug 27, 2021·Human Vaccines & Immunotherapeutics·Pasquale StefanizziSilvio Tafuri
Jul 17, 2019·Vaccine·Gaston De SerresDanuta M Skowronski